Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Albrecht H. Krämer
Final Two-Year Outcomes for the Sentry Bioconvertible Inferior Vena Cava Filter in Patients Requiring Temporary Protection from Pulmonary Embolism
In appropriately chosen patients, systematic reviews and meta-analyses have shown that inferior vena cava (IVC) filters are effective at providing mechanical protection against pulmonary embolism (PE) (1x1Angel, L.F., Tapson, V., Galgon, R.E., Restrepo, M.I., and Kaufman, J. Systematic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol. 2011; 22: 1522–1530 e1523 Google ScholarSee all References, 2x2Bikdeli, B., Chatterjee, S., Desai, N.R. et al.
Open Surgery for Ruptured Abdominal Aortic Aneurysm - 38 Years Experience at an Academic Center in Chile
Background Few series of ruptured abdominal aortic aneurysm (RAAA) from Latin America have been published. Objectives To report the outcomes of RAAA treated with open surgical repair (OSR) in a University Hospital in Chile. Secondary objectives are the identification of prognostic factors and survival rates. Methods Retrospective review of consecutive RAAA patients treated with OSR between September 1979 and December 2017. Medical records, diagnostic images, and follow-up details were obtained.
Juxtarenal Abdominal Aortic Aneurysm: Results Of Open Surgery In An Academic Center
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Figure 1 Survival analysis with Kaplan Meier curve ABSTRACT Objectives To report our experience with conventional surgery for juxtarenal abdominal aortic aneurysms (JRA) by evaluating incidence of acute renal failure and perioperative mortality.
One-Year Analysis of the Prospective Multicenter SENTRY Clinical Trial: Safety and Effectiveness of the Novate Sentry Bioconvertible Inferior Vena Cava Filter - Journal of Vascular and Interventional Radiology
In the present imaging-intense IDE trial of the Sentry bioconvertible IVC filter, the composite primary end point of clinical success at 6 months was achieved in 97.4% of evaluable patients (111/114), with the 92.5% lower limit of the 95% CI surpassing the 80% SIR trial performance objective.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Albrecht H.
Contact Albrecht H., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack